5th International Congress on Personalized Therapy for Non-Small-Cell Lung Cancer and Head & Neck Cancer

This webcast is jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

This activity is supported by educational grants from: Boehringer Ingelheim Pharmaceuticals, Inc, Genentech, Lilly USA, LLC, Bristol-Myers Squibb and Astellas.

Specialty: Hematology/Oncology

Release date: November 5, 2013

Valid through: November 5, 2014

Target Audience:

This webcast is directed primarily to oncologists, registered nurses, physician assistants, nurse practitioners and pharmacists interested in new developments for treatment of non-small-cell lung cancer (NSCLC).

Program Overview:

This series of webcasts is intended to improve care of patients with NSCLC by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of molecular profiling and personalized therapies at various stages of clinical development will be given significant focus. These enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This program consists of 8 continuing education activites.

Module 1 — Mark Kris, MD — 0.75 AMA PRA Category 1™ Credit Hours

Module 2 — C. Langer, MD & J. Weiss, MD — 1.0 AMA PRA Category 1™ Credit Hour

Module 3 — Tanguy Seiwert, MD — 1.0 AMA PRA Category 1™ Credit Hour

Module 4 — Mark Kris, MD — 0.75 AMA PRA Category 1™ Credit Hours

Module 5 — S. Gettinger, MD & P. Paik, MD — 1.0 AMA PRA Category 1™ Credit Hour

Module 6 — A. Vachani, MD & T. Evans, MD — 1.0 AMA PRA Category 1™ Credit Hour

Module 7 — H. Borghaei, DO, MS & B. Eaby-Sandy, CRNP — 1.0 AMA PRA Category 1™ Credit Hour

Module 8 — Dwight D. Kloth, PharmD, FCCP, BCOP — 0.5 AMA PRA Category 1™ Credit Hours